---
title: "Provision of Sequencing Panel for Detection of Gene Fusions In Cancer"
ocid: "ocds-h6vhtk-02b8e4"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02b8e4"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02b8e4.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02b8e4.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)"
published: "2021-06-07"
---

# Provision of Sequencing Panel for Detection of Gene Fusions In Cancer

Buyer: NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)  
Current stage: Planning  
OCID: ocds-h6vhtk-02b8e4

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02b8e4)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02b8e4.json)

## Summary

The NHS Wales Shared Services Partnership, hosted by Velindre University NHS Trust, is planning to procure an RNA sequencing panel aimed at detecting gene fusions in cancer tissues. This procurement falls under the goods category, specifically laboratory reagents, and is currently in the planning stage. The anticipated invitation to tender is expected to be published in autumn 2021, with the intention to commence service delivery by spring 2022. The delivery location for the procured items will be the All Wales Genomics Laboratory, situated in Cardiff, Wales. Interested suppliers are invited to present their solutions via virtual meetings between 5th and 16th July 2021.

This tender presents significant opportunities for businesses in the biotechnology and diagnostic sectors, particularly those with experience in RNA sequencing and genomic testing technologies. Companies with innovative laboratory reagents or those capable of providing efficient and automated solutions for gene fusion detection will find this tender well-suited to their capabilities. By participating in this procurement, businesses can not only contribute to advancing genomic research but also expand their reach within the healthcare market in Wales.

## Notice

The All Wales Genomics Laboratory intends to procure an RNA sequencing panel to enable the identification of gene fusion events in somatic tissue samples, to replace the current laboratory tests. AWGL currently offers a range of gene fusion detection services using predominantly fluorescence in situ hybridisation (FISH) together with a limited number of qPCR assays. These tests cover the common genetic translocations seen in haematological malignancies, lymphomas, sarcomas and solid tumour referrals in a range of tissues including bone marrow, peripheral blood and formalin-fixed paraffin embedded (FFPE) tissues.

### Lot Information

Lot 1

The All Wales Genomics Laboratory intends to procure an RNA sequencing panel to enable the identification of gene fusion events in somatic tissue samples. AWGL currently offers a range of gene fusion detection services using predominantly fluorescence in situ hybridisation (FISH) together with a limited number of qPCR assays. These tests cover the common genetic translocations seen in haematological malignancies, lymphomas, sarcomas and solid tumour referrals in a range of tissues including bone marrow, peripheral blood and formalin-fixed paraffin embedded (FFPE) tissues. In 2020/21 the laboratory received referrals from over 3000 samples for gene fusion translocation testing. Many of these samples were interrogated for more than 1 gene fusion event. The laboratory intends to introduce and NGS assay that will ensure the following objectives are met- - Workflow Standardisation - Introduction of a single NGS assay that can be used to detect a variety of clinically relevant gene fusions, across a range of sample types and cancers. - Streamlining Analysis - NGS assay allows the transfer of fusion analysis from predominantly microscopy based analyses (FISH) to a more sensitive and standardised method. - Service Improvement - Allows reduction of turnaround times by simultaneous detection of all clinically relevant gene fusion events using a protocol that is amenable to automation. - Expansion of gene fusion testing repertoire - Flexibility in panel content for future proofing against new testing requirements in cancer. We anticipate that an invitation to tender will be published in autumn 2021, with a view to begin service delivery in spring 2022. AWGL invite suppliers to present their solution via Teams/Skype/Zoom on a mutually convenient time/date between Monday 5th July and Friday 16th July 2021. The presentation should detail how your solution may best meet our needs with time for questions at the end. Please contact Ryan James, ryan.james3@wales.nhs.uk to arrange a meeting, where you will be provided a list of information that the laboratory requests you cover in your presentation.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/012659-2021 |
| Notice type | Planning Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 7 Jun 2021 |
| Submission deadline | Not specified |
| Future notice date | 30 Sep 2021 |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planned |
| Lots status | Planned |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST) |
| Locality | CARDIFF |
| Post town | Cardiff |
| Postcode | CF15 7QZ |
| Country | Wales |
| ITL 1 | TLL Wales |
| ITL 2 | TLL5 South East Wales |
| ITL 3 | TLL51 Central Valleys and Bridgend |
| Local authority | Rhondda Cynon Taf |
| Electoral ward | Taff's Well |
| Westminster constituency | Cardiff North |
| Delivery location | TLL22 Cardiff and Vale of Glamorgan |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33696500 - Laboratory reagents

## Release History

- 7 Jun 2021 at 11:15 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/012659-2021

## Notice URLs

- http://nwssp.nhs.wales/ourservices/procurement-services/
- https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=111195
- https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02b8e4. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02b8e4.json.